Viridian Therapeutics, Inc.\DE Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Viridian Therapeutics, Inc.\DE quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Viridian Therapeutics, Inc.\DE Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.4M, a 29.4% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.4M +$545K +29.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.83M -$244K -11.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.48M +$14K +0.95% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.67M +$60K +3.73% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.86M +$608K +48.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.07M +$665K +47.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.47M -$75K -4.86% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.61M -$70K -4.17% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.25M -$214K -14.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.41M -$162K -10.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.54M -$57K -3.56% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $1.68M +$1.2M +251% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.46M +$971K +198% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $1.57M +$983K +168% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.6M +$1.33M +502% Mar 31, 2021 10-Q 2024-08-08
Q4 2020 $478K +$478K Dec 31, 2020 10-K 2022-03-11
Q3 2020 $490K Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $584K Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $266K Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $0 Dec 31, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.